Novo Integrated Sciences Inc., a primary healthcare service provider, appointed Robert Mattacchione as CEO and board chairman.

Mattacchione is a majority stakeholder in the Bellevue, Wash.-based company and the co-founder of its Canadian subsidiary Novo Healthnet Ltd. He will replace the outgoing board chairman Pierre Dalcourt, who will remain on the board.

Novo Integrated Sciences owns 14 clinics and has 150 affiliate clinics, retirement homes, long-term care facilities and institutional locations in Canada.